EFX vs JBHT

EFX presents a dichotomy between strong operational growth and deteriorating market sentiment. While the Piotroski F-Score of 6/9 indicates stable financial health and the company maintains impressive YoY earnings growth of 34%, the technical trend is severely bearish (0/100) with the stock trading near its 52-week low. The current price of $172.47 is closely aligned with the growth-based intrinsic value ($167.26) but significantly exceeds the defensive Graham Number ($69.68). Liquidity concerns are evident in the low current ratio (0.61), and aggressive insider selling by the CEO and other officers adds to the bearish outlook despite a 'Buy' analyst consensus.

JBHT presents a dichotomy of strong earnings efficiency against a backdrop of declining revenue and significant overvaluation. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the current price of $224.17 trades at a massive premium to the Graham Number ($73.96) and above the growth-based intrinsic value ($190.28). While earnings growth is robust (+23.6% YoY), the negative revenue growth and bearish insider sentiment suggest the recent 67% price surge may be unsustainable. The stock is currently trading above the average analyst target price, limiting immediate upside potential.